Malady Kyle
- SEC CIK
- 0001760581
In the past year, 6 open-market sale filings worth $327.9K and no purchases.
Current role at each company
- VZ Verizon Communications IncEVP and Group CEO-VZ Businessas of Sep 23, 2026
- DXCM Dexcom IncDirectoras of Jun 1, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $327.9K
- 6 filings
- Net
- −$327.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Malady Kyle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VZ Verizon Communications Inc
EVP and Group CEO-VZ Business20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 (view filing) | Mar 13-14 | 2 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −14.7K | $36.62 | −$540.0K | −16.6%74.2K after | 2 lots |
| Mar 17, 2023 (view filing) | Mar 15 | 2 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −6.23K | $36.69 | −$228.4K | −8.4%68.0K after | |
| Feb 20, 2024 (view filing) | Feb 15 | 5 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −15.0K | $40.33 | −$605.0K | −20.2%59.2K after | |
| Feb 26, 2024 (view filing) | Feb 22 | 4 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −24.0K | $40.80 | −$979.2K | −40.5%35.2K after | |
| Jan 29, 2025 (view filing) | Jan 27 | 2 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −20.0K | $40.54 | −$810.8K | −30.5%45.7K after | |
| Jan 30, 2025 (view filing) | Jan 28 | 2 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −20.0K | $40.49 | −$809.8K | −43.8%25.7K after | |
| Jan 31, 2025 (view filing) | Jan 29 | 2 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −11.1K | $40.88 | −$453.2K | −43.2%14.6K after | |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −8.00K | $39.89 | −$319.1K | −54.8%6.59K after | |
| Feb 6, 2025 (view filing) | Feb 4 | 2 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −6.59K | $39.70 | −$261.6K | −100.0%0 after | |
| Apr 24, 2025 (view filing) | Apr 23 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −5.00K | $42.49 | −$212.4K | −12.0%36.5K after |
DXCM Dexcom Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 (view filing) | Sep 5 | 4 days | Malady KyleDirector | SSale | −667 | $80.86 | −$53.9K | −2.9%22.7K after | 10b5-1 |